241 related articles for article (PubMed ID: 25446898)
1. Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma.
Chen Z; Liu C; Patel AJ; Liao CP; Wang Y; Le LQ
Cancer Cell; 2014 Nov; 26(5):695-706. PubMed ID: 25446898
[TBL] [Abstract][Full Text] [Related]
2. NF GEMMs already! The power and promise of mouse tumor models.
Gutmann DH
Cancer Cell; 2014 Nov; 26(5):596-9. PubMed ID: 25517743
[TBL] [Abstract][Full Text] [Related]
3. The role of nerve microenvironment for neurofibroma development.
Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
[TBL] [Abstract][Full Text] [Related]
4. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.
Wu J; Williams JP; Rizvi TA; Kordich JJ; Witte D; Meijer D; Stemmer-Rachamimov AO; Cancelas JA; Ratner N
Cancer Cell; 2008 Feb; 13(2):105-16. PubMed ID: 18242511
[TBL] [Abstract][Full Text] [Related]
5. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.
Le LQ; Shipman T; Burns DK; Parada LF
Cell Stem Cell; 2009 May; 4(5):453-63. PubMed ID: 19427294
[TBL] [Abstract][Full Text] [Related]
6. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
Brossier NM; Carroll SL
Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal Loss of
Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
[TBL] [Abstract][Full Text] [Related]
8. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
9. Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case report.
Spinner RJ; Scheithauer BW; Perry A; Amrami KK; Emnett R; Gutmann DH
J Neurosurg; 2007 Aug; 107(2):435-9. PubMed ID: 17695403
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
11. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.
Le LQ; Liu C; Shipman T; Chen Z; Suter U; Parada LF
Cancer Res; 2011 Jul; 71(13):4686-95. PubMed ID: 21551250
[TBL] [Abstract][Full Text] [Related]
12. Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma.
Beert E; Brems H; Renard M; Ferreiro JF; Melotte C; Thoelen R; De Wever I; Sciot R; Legius E; Debiec-Rychter M
Genes Chromosomes Cancer; 2012 Sep; 51(9):852-7. PubMed ID: 22585738
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
14. NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies.
Ponti G; Martorana D; Pellacani G; Ruini C; Loschi P; Baccarani A; De Santis G; Pollio A; Neri TM; Mandel VD; Maiorana A; Maccio L; Maccaferri M; Tomasi A
Anticancer Res; 2014 Jun; 34(6):3021-30. PubMed ID: 24922668
[TBL] [Abstract][Full Text] [Related]
15. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
16. Malignant schwannoma of the sciatic nerve originating in a spinal plexiform neurofibroma associated with neurofibromatosis type 1--case report.
Topsakal C; Akdemir I; Tiftikci M; Ozercan I; Aydin Y
Neurol Med Chir (Tokyo); 2001 Nov; 41(11):551-5. PubMed ID: 11758709
[TBL] [Abstract][Full Text] [Related]
17. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
18. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.
Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA
Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.
Plante C; Mohamad T; Hewa Bostanthirige D; Renaud M; Sidhu H; ElChoueiry M; Vatasescu JS; Poirier M; Geha S; Brosseau JP
PLoS One; 2024; 19(6):e0301040. PubMed ID: 38900740
[TBL] [Abstract][Full Text] [Related]
20. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line.
Perrin GQ; Fishbein L; Thomson SA; Thomas SL; Stephens K; Garbern JY; DeVries GH; Yachnis AT; Wallace MR; Muir D
J Neurosci Res; 2007 May; 85(6):1347-57. PubMed ID: 17335073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
